Candid Therapeutics
ClosedCandid Therapeutics is a biotech company in San Diego, United States, founded in 2024. It has raised $875.0M across 2 rounds, most recently a $505.0M Venture Round in March 2026.
Rewriting the Biology of Autoimmune Disease
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2024
- Business Model
- B2B
- Website
- candidtx.com
- Total Funding
- $875.0M
- Last Round
- $505.0M Venture RoundMar 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds for this company. The full record is or through the API.
About
Candid Therapeutics is a clinical-stage biopharmaceutical company developing bispecific antibody therapies for autoimmune and inflammatory diseases. Founded in 2023 and backed by $370M in funding, the company is building a pipeline of next-generation immunology treatments targeting unmet medical needs in conditions such as lupus and myasthenia gravis.
Summary
It lists 11–50 employees. It has raised $875.0M in total across 2 rounds, most recently a $505.0M Venture Round in Mar 2026.
Funding & Exit History
Mar 2026
Sign up to see all 3 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Similar Companies

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/candid-therapeutics"><img src="https://indexed.vc/api/badge/company/candid-therapeutics" alt="Candid Therapeutics on Indexed.vc" width="260" height="76" /></a>